Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Gross Profit: 2015-2025

Historic Gross Profit for Aytu Biopharma (AYTU) over the last 11 years, with Jun 2025 value amounting to $45.8 million.

  • Aytu Biopharma's Gross Profit fell 23.35% to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.0 million, marking a year-over-year decrease of 10.35%. This contributed to the annual value of $45.8 million for FY2025, which is 6.57% down from last year.
  • Per Aytu Biopharma's latest filing, its Gross Profit stood at $45.8 million for FY2025, which was down 6.57% from $49.1 million recorded in FY2024.
  • Aytu Biopharma's Gross Profit's 5-year high stood at $66.6 million during FY2023, with a 5-year trough of $29.2 million in FY2021.
  • In the last 3 years, Aytu Biopharma's Gross Profit had a median value of $49.1 million in 2024 and averaged $53.8 million.
  • In the last 5 years, Aytu Biopharma's Gross Profit spiked by 79.05% in 2022 and then fell by 26.38% in 2024.
  • Over the past 5 years, Aytu Biopharma's Gross Profit (Yearly) stood at $29.2 million in 2021, then spiked by 79.05% to $52.3 million in 2022, then increased by 27.44% to $66.6 million in 2023, then decreased by 26.38% to $49.1 million in 2024, then declined by 6.57% to $45.8 million in 2025.